Neurocrine Biosciences Inc (NBIX) Shares Down 3.14% on Mar 30

NodeGuardian · 2026-04-10T12:21:24+00:00

Neurocrine Biosciences Inc (NBIX) shares fell 3.14% to $128.30, remaining below its 52-week high. Analysts rate it as "Outperform" with a target price of $176.27, indicating a potential upside.

NodeGuardian

2026-04-10 12:21:24

Abstract generation in progress

Neurocrine Biosciences Inc (NBIX) shares dropped 3.14% on March 30, trading at $128.30 after touching an intraday low of $128.02. This price is 19.90% below its 52-week high but 52.32% above its 52-week low. Wall Street analysts maintain an “Outperform” rating with an average target price of $176.27, suggesting a potential upside of 37.39%, while GuruFocus estimates a GF Value of $207.07.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes